MONTREAL, Sept. 14, 2020 /CNW/ - Mondias Natural
Products Inc. (TSXV: NHP) (the "Company" or "Mondias ")
is pleased to announce the results of its annual general and
special meeting of shareholders (the "Meeting"), which was held
earlier today by webcast. All of the nominees listed in the
Company's management information circular dated August 14, 2020, were elected as directors.
Detailed results of the vote for the election of directors are
set out below:
Nominee
|
Votes
FOR
|
%
FOR
|
Votes
Withheld
|
%
Withheld
|
Marie
Bélanger
|
39,207,298
|
91.11%
|
3,823,406
|
8.89
|
Kevin Cole
|
39,207,298
|
91.11%
|
3,823,406
|
8.89
|
Nathalie
Nasseri
|
39,207,298
|
91.11%
|
3,823,406
|
8.89
|
Mario
Paradis
|
39,207,298
|
91.11%
|
3,823,406
|
8.89
|
Kevin
Roland
|
39,207,298
|
91.11%
|
3,823,406
|
8.89
|
All other matters presented for shareholder approval at the
Meeting were approved, as follows:
- to set the number of directors at a minimum of three (3) and
maximum of seven (7);
- to appoint UHY McGovern Hurley LLP, Chartered Accountants as
the auditors of the Corporation and to authorize the directors to
fix the auditors' remuneration;
- to consider, and if deemed advisable, to pass, with or without
variation, an ordinary resolution confirming re-approval of the
Corporation's incentive stock option plan;
- to consider, and if deemed advisable, to pass, with or without
variation, an ordinary resolution authorizing and approving the
acquisition of 100% of the issued and outstanding common shares of
Lumiera Health Innovation Inc.; and
- to consider and, if deemed appropriate, to pass, with or
without variation, a special resolution approving, ratifying and
confirming a change of name of the Corporation from"Mondias Natural
Products Inc."/"Produits Naturels Mondias inc." to "Lumiera Health
Innovation Inc.";
About Mondias Natural Products Inc.
Mondias specializes in the commercialization and development of
evidence-based botanical products for the healthcare and
bio-agriculture. The Company sells both oral and topical botanical
agents to help manage unmet medical needs through its Holizen
Laboratories division. Mondias is also developing botanical-based
specialty fertilizers for use on household plants, lawns and golf
courses and in urban gardens, nurseries and greenhouses, in
collaboration with McGill's Faculty of Agricultural and
Environmental Sciences. For more information, visit: www.mondias.ca
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking
information. All statements, other than statements of historical
fact, that address activities, events or developments that the
Company believes, expects or anticipates will or may occur in the
future (including, without limitation, statements regarding
potential acquisitions and financings) are forward-looking
statements. Forward-looking statements are generally identifiable
by the use of the words "may", "will", "should", "continue",
"expect", "anticipate", "estimate", "believe", "intend", "plan" or
"project" or the negative of these words or other variations on
these words or comparable terminology. Forward-looking statements
are subject to a number of risks and uncertainties, many of which
are beyond the Company's ability to control or predict, that may
cause the actual results of the Company to differ materially from
those discussed in the forward-looking statements. Factors that
could cause actual results or events to differ materially from
current expectations include the Company's inability to obtain
sufficient financing to execute its business plan; competition;
regulation; anticipated and unanticipated costs and delays; the
success of the Company's research and development strategies; the
ability to obtain orphan drug status; the applicability of the
discoveries made; the successful and timely completion and
uncertainties related to the regulatory approval process; the
timing of clinical trials; the timing and outcomes of regulatory or
intellectual property decisions; and other risks disclosed in the
Company's public disclosure record on file with the relevant
securities regulatory authorities. Although the Company has
attempted to identify important factors that could cause actual
results or events to differ materially from those described in
forward-looking statements, there may be other factors that cause
results or events not to be as anticipated, estimated or intended.
Readers should not place undue reliance on forward-looking
statements. The forward-looking statements in this news release are
made as of the date of this news release, and the Company does not
undertake any obligation to publicly update them to reflect new
information or subsequent events or otherwise except as required by
applicable securities legislation.
SOURCE Mondias Natural Products Inc.